Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Adam Fabisiak
Observed names:
A Fabisiak,
A. Fabisiak,
Fabisiak, Adam
Institution:
Medical University of Lodz
Observed institution:
Medical University of Lodz
ORCID:
0000-0002-6997-4925
Observed ORCID:
0000-0002-6997-4925
OpenAlex ID:
A5009626579
Works
56
Awards
1
LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
2016
·
Adam Fabisiak
, Natalia Murawska
, et al.
·
Pharmacological Reports
·
170
Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases
2014
·
Marta Sobczak
, Adam Fabisiak
, et al.
·
Pharmacological Reports
·
108
Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment
2016
·
Natalia Murawska
, Adam Fabisiak
, et al.
·
Inflammatory Bowel Diseases
·
105
Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2017
·
Natalia Fabisiak
, Adam Fabisiak
, et al.
·
Journal of Clinical Gastroenterology
·
97
Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
2017
·
Adam Fabisiak
, Jakub Włodarczyk
, et al.
·
Journal of Neurogastroenterology and Motility
·
67
PDF
Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases
2019
·
Adrian Bartoszek
, Ee Von Moo
, et al.
·
Pharmacological Research
·
66
Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
2021
·
Patrycja Dudek
, Adam Fabisiak
, et al.
·
Journal of Clinical Medicine
·
48
PDF
Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice
2021
·
Maciej Salaga
, Adrian Bartoszek
, et al.
·
Nutrients
·
32
PDF
Advancements in dual biologic therapy for inflammatory bowel diseases: efficacy, safety, and future directions
2025
·
Adam Fabisiak
, Miłosz Caban
, et al.
·
Therapeutic Advances in Gastroenterology
·
26
Salvinorin A analogues PR ‐37 and PR ‐38 attenuate compound 48/80‐induced itch responses in mice
2015
·
M Salaga
, P R Polepally
, et al.
·
British Journal of Pharmacology
·
22
Novel selective agonist of GPR18, PSB‐KK‐1415 exerts potent anti‐inflammatory and anti‐nociceptive activities in animal models of intestinal inflammation and inflammatory pain
2020
·
Adam Fabisiak
, Natalia Fabisiak
, et al.
·
Neurogastroenterology & Motility
·
20
Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases
2020
·
Natalia Fabisiak
, Adam Fabisiak
, et al.
·
Pharmacological Reports
·
17
PDF
Cannabinoids as gastrointestinal anti‐inflammatory drugs
2017
·
A. Fabisiak
, J. Fichna
·
Neurogastroenterology & Motility
·
16
Discharge protocol in acute pancreatitis: an international survey and cohort analysis
2023
·
Rita Nagy
, Klementina Ocskay
, et al.
·
Scientific Reports
·
14
Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis – a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial
2024
·
Renata Talar-Wojnarowska
, Adam Fabisiak
, et al.
·
Frontiers in Medicine
·
10
PDF
Antinociceptive potency of enkephalins and enkephalinase inhibitors in the mouse model of colorectal distension—proof‐of‐concept
2018
·
Adam Fabisiak
, Małgorzata Sobocińska
, et al.
·
Chemical Biology & Drug Design
·
10
Usefulness of Contrast-Enhanced Ultrasound in the Differentiation between Hepatocellular Carcinoma and Benign Liver Lesions
2023
·
Adam Dobek
, Mateusz Kobierecki
, et al.
·
Diagnostics
·
9
PDF
Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
2019
·
Adrian Bartoszek
, Jakub Fichna
, et al.
·
Current Drug Targets
·
9
A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
2022
·
Maria Wołyniak
, Ewa Małecka-Wojciesko
, et al.
·
Journal of Clinical Medicine
·
8
PDF
Neurological Manifestations and Psychiatric Disorders in the Course of Inflammatory Bowel Diseases
2022
·
Patrycja Głuch
, Agnieszka Swiatek
, et al.
·
Journal of Gastrointestinal and Liver Diseases
·
8
PDF
Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis
2019
·
Adam Fabisiak
, Marcin Włodarczyk
, et al.
·
Journal of Gastrointestinal and Liver Diseases
·
8
PDF
Purtscher’s-like retinopathy as a rare complication of acute alcoholic pancreatitis
2021
·
Michalina M. Wieczorek
, Miłosz Caban
, et al.
·
Gastroenterology Review
·
7
Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
2020
·
Adam Fabisiak
, Adrian Bartoszek
, et al.
·
Journal of Clinical Medicine
·
7
PDF
Dietary fatty acid content influences the expression of genes involved in the lipid turnover and inflammation in mouse colon and spleen
2019
·
Paula Mosińska
, Aleksandra Tarasiuk
, et al.
·
Pharmacological Reports
·
7
PDF
Association Between Temporomandibular Disorders and Irritable Bowel Syndrome: A Scoping Review
2024
·
Klara Saczuk
, Sylwia Roszuk
, et al.
·
Journal of Clinical Medicine
·
6
PDF
Show more works
View as search
Works count:
56
Citation count:
945
H-index:
14
I10-index:
16
Year
Topic
Type